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Abstract
Background: Recent advances in sequencing technologies have enabled generation of large-scale genome
sequencing data. These data can be used to characterize a variety of genomic features, including the DNA copy
number profile of a cancer genome. A robust and reliable method for screening chromosomal alterations would
allow a detailed characterization of the cancer genome with unprecedented accuracy.
Results: We develop a method for identification of copy number alterations in a tumor genome compared to its
matched control, based on application of Smith-Waterman algorithm to single-end sequencing data. In a
performance test with simulated data, our algorithm shows >90% sensitivity and >90% precision in detecting a
single copy number change that contains approximately 500 reads for the normal sample. With 100-bp reads, this
corresponds to a ~50 kb region for 1X genome coverage of the human genome. We further refine the algorithm
to develop rSW-seq, (recursive Smith-Waterman-seq) to identify alterations in a complex configuration, which are
commonly observed in the human cancer genome. To validate our approach, we compare our algorithm with an
existing algorithm using simulated and publicly available datasets. We also compare the sequencing-based profiles
to microarray-based results.
Conclusion: We propose rSW-seq as an efficient method for detecting copy number changes in the tumor
genome.
Background
Human solid tumors harbor various types of chromoso-
mal alterations, many of which play a role in the initia-
tion and progression of the disease [1,2]. As a major
category of chromosomal alterations, DNA copy number
alterations (CNAs) that represent chromosomal gains or
losses have been extensively investigated in cancer
research. Many CNAs can affect the function or struc-
ture of cancer-related genes and are associated with cau-
sative molecular mechanisms in carcinogenesis. Thus, a
comprehensive catalogue of CNAs in a given tumor
type is an important step in understanding the underly-
ing carcinogenic mechanisms and in highlighting poten-
tial biomarkers with diagnostic or therapeutic
implications.
In recent years, high-resolution array Comparative
Genomic Hybridization (array-CGH) has become a
standard platform for identification of CNAs in a gen-
ome-scale and great progress has been made in profiling
of cancer-related chromosomal alterations with
improved spatial resolution [3,4]. In spite of the many
successes, array-CGH has several limitations inherent in
hybridization-based techniques, such as noise due to
cross-hybridization between probe and target sequences
as well as a limited and nonlinear dynamic range. In
addition, the resolution and genome coverage of an
array-CGH platform are dependent on a fixed set of
probes, making it difficult to identify novel alterations
below a given size [5].
The first use of sequencing data in genome-wide iden-
tification of CNAs was digital karyotyping [6]. Its utility,
however, was limited by the cost of conventional Sanger
sequencing method. Fortunately, the recent arrival of
next-generation sequencing technology has altered the
situation dramatically. This technology allows large-scale
sequencing data to be generated with significantly lower
cost and higher throughput [7,8]. Although the advan-
tage of this sequencing technology has been already
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[9,10], more accurate and robust methods are needed
for identification of copy number alterations for the
large amount of whole-genome sequencing data that
will be generated in the near future.
There are two classes of methods for copy number
assessment, both based on the assumption that the local
density of sequenced reads is proportional to the copy
number. The first is to estimate copy number in a single
sample, typically to identify copy number variation
(CNV) of a non- diseased individual (although there is
no consensus, CNV often refers to all alterations, both
germline and somatic, in contrast to CNA for somatic
alterations). In this case, a ‘read depth’ can be measured
for non-overlapping genomic windows and used to iden-
tify CNVs with respect to a reference genome. This
strategy has been addressed elsewhere [11,12], but it is
complicated by other factors, such as local GC content,
that affect the read density significantly. The second
class of methods is to estimate copy number in one gen-
ome compared to its control, typically in a disease tissue
v e r s u san o r m a lt i s s u ef r o mt h es a m ei n d i v i d u a l .T h i s
has the advantage of controlling for patient-specific
CNVs, thus shifting the focus to somatic alterations.
T h ed i s a d v a n t a g ei st h a tt h en u m b e ro fe x p e r i m e n t s
required is doubled. In this study, we propose a method
for the second case in which sequencing reads are avail-
able for two matched genomes. We focus on cancer
genomes here, but it can be applied to comparison of
any two genomes.
With the sequencing data from the tumor and its
paired normal genomes, CNAs are characterized by a
disproportionately higher number of tumor reads (copy
number gains) or normal reads (losses). Theoretically,
the spatial resolution and the dynamic range of the
detected copy number changes are limited only by
the sequencing depth, unlikei nt h ef i x e dr e s o l u t i o no f
the array-CGH platforms. The approach we take is
based on a modification of the Smith-Waterman algo-
rithm [13]. This idea was previously proposed for analy-
sis of array-CGH [14]. Here, we adapt it for sequencing
data and introduce further improvements. In simulation
tests, our method is able to detect even a single copy
change in a region with high sensitivity and precision.
To identify a set of alterations in a multilayered config-
uration with different copy numbers, we propose a
recursive version of the method called rSW-seq (recur-
sive Smith-Waterman-seq). We compare our method
with a previously published algorithm SegSeq [15], using
simulated and publicly available sequencing data.
Results and Discussion
We start with sequencing datasets obtained from a tumor
and its matched normal genomes. Under the null
hypothesis of no copy number difference, a genomic seg-
ment would have an expected read ratio close to (total
number of tumor reads)/(total number of normal reads). A
read ratio showing substantial deviation from this expected
ratio would be indicative of copy number alterations. One
simple approach is to use a moving-window to generate
read ratios along the genome, analogous to the probe-spe-
cific intensity ratios in conventional array-CGH profiles.
Then, a known segmentation algorithm designed for array-
CGH data can be applied [16,17]. However, this is compu-
tationally expensive for the sequencing data and does not
take full advantage of the data. Alternatively, one can use
the density of reads to determine whether the ratio is sig-
nificantly different from 1 for each window based, for
instance, on the normal or Poisson distribution. Then the
neighboring windows with significant amplification or dele-
tion can be joined together. A sliding window of fixed
width is simplest, but because this results in unstable ratios
in regions with small read counts, a window may be
defined by a fixed number of reads in the normal sample.
Non-overlapping windows are typically used, as this makes
tests in adjacent regions independent and reduces the com-
putational burden; but overlapping windows can be also
used, especially to generate a smoothed profile. SegSeq, a
recently proposed sequencing-based algorithm, utilizes
windows defined by a predefined number of normal reads
to detect breakpoints between CNAs [15]. A major disad-
vantage of window-based approaches, however, is that the
window size must be determined a priori,a n dt h a tt h e
overall performance of the algorithm is influenced strongly
by that value. For example, a larger window size enhances
the confidence level of CNAs identified [18], but too large
a window sacrifices spatial resolution. The method we pro-
pose below avoids having to define a window.
Description of the algorithm
The sequencing reads from tumor and matched normal
genome are combined and sorted in a non-decreasing
order according to their genomic positions (Figure 1A).
The reads from tumor and normal genomes are distin-
guished and assigned different weight values of WT and
WN, respectively. When the number of reads for the
tumor and normal samples (NT and NN, respectively)
are equal, they are assigned equal weight but with differ-
ent signs (e.g., WT =1a n dWN =- 1 ) .O t h e r w i s e ,( NT ≠
NN), the weights for tumor and normal reads are set
given the NT and NN (e.g, WT =2×NN/(NT + NN)a n d
WN =- 2×NT/(NT + NN)) This equalizes the total sum
of WT and −= − ( ) ∑ ∑ WW W NT N
N N N T
1 1 ,m a k i n gt h e
sum of all WT and WN to be zero. Thus, the sequencing
data from tumor and matched normal genome is con-
verted into a one-dimensional vector of WT and WN,
amenable to an algorithm for pattern detection.
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positive or negative cumulative sum in this vector of
weight values indicates a local copy number gain or
loss, respectively. As shown in Figure 1A, the local copy
number gain (prevalence of tumor reads over normal
reads) results in an upward slope of the cumulative
sum. To identify the alterations and to map the bound-
aries accurately and rapidly in this cumulative sum pro-
file, we propose to use the Smith-Waterman algorithm.
This algorithm was originally developed to determine
highly conserved, consecutive nucleotides in the local
sequence alignment problem [13]. The use of the
Smith-Waterman algorithm for copy number analysis
was previously proposed by Price et al. [14] for array-
CGH data in their SW-ARRAY algorithm. We have
found that this algorithm is also suitable for copy num-
ber estimation from sequencing data with appropriate
modifications. Thus, in this work, we have adopted the
modified Smith-Waterman algorithm to map the copy
number changes.
In this method, the tumor-specific copy number gains
and losses are identified separately. Assume that the
reads on a chromosome are r1 =( W1,s1),...,rn =( Wn,s n),
where Wj and sj are the weight and the mapped location
associated with the read rj, respectively. Since the short
reads are ordered, we have s1 ≤ s2 ≤...≤ sn For copy
number gain, the algorithm searches for the segment [sl,
sm] such that the partial cumulative sum
Slm W j jl
m
(, )=
= ∑ is maximized. Then we iterate until
no more alternation can be found.
Specifically, let l1 = 1 and ll l S l l W kk kj jl
l
k + = =≥ = < + ∑ 1 01 min{ : ( , ) } ,
i.e., lk+1 -1is the first index after lk such that. S(lk,l )<0
(l >lk) Suppose that after certain k ≥ 1, we have S(lk,l ) ≥
0f o ra l ll ≥ lk.D e n o t elk+1 = n +1 .W et h e nl e tmk =
argmax {S(lk,m ), m Î [lk,lk+1]}, i.e., mk is the index
between lk and lk+1 such that S(lk,m )i sm a x i m i z e d .
Then, the partial cumulative sums S(lk,m k) will be max-
imized at some k0 Î {1,...,K}. One can show that the seg-
ment SS lm kk 00 , ⎡
⎣
⎤
⎦ is the maximum segment [sl,s m] that
maximizes the partial cumulative sum
Slm W j jl
m
(, )=
= ∑ over all 1 ≤ l ≤ m ≤ n (see Methods).
The algorithm rSW-seq just iteratively searches for lk
and mk, starting from l1 = 1. Once the maximum seg-
ment SS lm kk 00 , ⎡
⎣
⎤
⎦ is identified, the region will be
reported as a copy gain region if SS S lm kk 000 , () > .
Then, the algorithm will mask this region, i.e., setting
the weights Wjof the reads in this region to be zero, and
search for the next copy gain region until no further
Figure 1 A schematic of the algorithm. (A) The sequencing reads for tumor (red triangles) and matched normal genomes (black triangles) are
shown. The reads are ordered according to their chromosomal location and converted into a one-dimensional array for pattern detection. Tumor
(T) and normal (N) reads are given the weight values WT and WN, respectively (in this example, +1 and -1 for simplicity). The cumulative sum of
weight values shows an upward slope (indicated by the box) for a region of local copy number gain (prevalence of tumor reads over normal
reads). (B) The upward slope in the cumulative sum and the flanking flat lines correspond to a local copy number gain and regions of no copy
number change, respectively (top). For improved performance, the threshold t is subtracted from weight values to give a negative slope to
regions of no copy number differences while maintaining the positive slope for the copy number gain (bottom).
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losses, the same method can be applied to the original
array of weight values with the signs inverted for WT
and WN. The pseudo-code for detecting positive-scoring
segment is available in Methods. In practice, one does
not scan the whole chromosome again for the next
region of interest; instead, a ranked list of candidates [sl,
sm] is kept and only the neighborhood of the identified
variant is scanned again.
In Figure 1, the cumulative sum S should be close to
zero in the regions of no copy number changes. How-
ever, a noisy distribution of reads might lead to a fluctu-
ating pattern of local S and increase false positives in
the selection of positive-scoring segments. To make the
algorithm robust to noise, we subtract a predefined
threshold level t from the weight values WT and WN
globally. This adjustment gives a negative slope to
regions with no copy number changes in the cumulative
sum plot while maintaining the positive slope of the
copy number gains (Figure 1B). This preprocessing
helps to minimize the false positives without losing
accuracy in mapping the boundaries of true copy num-
ber alterations. This point is illustrated with an example
in the next section.
Simulation tests
To measure the performance of the algorithm, we gen-
erated a set of 100 Mb artificial chromosomes on which
1 million random reads are mapped (See Methods for
details on simulated data). The dependency of the algo-
rithm on different sequencing depths is discussed later.
We assume that the same numbers of virtual reads (half
million reads each) are derived from the tumor and nor-
mal genomes. The tumor reads are positioned to gener-
ate regions of copy number ratios 3/2 or 1/2,
corresponding to a single copy number of gain or loss,
respectively. The single copy alterations were selected
for the performance test since they represent the mini-
mal ratio difference between tumor and normal reads,
making them the most difficult to find. Different altera-
tion sizes (10 kb to 1 Mb in 8 scales) were simulated
with 100 artificial chromosomes for each size category.
First, we tested the algorithm for a wide range of t
threshold values (16 levels, from 0 to 0.3 stepping at
0.02) and compared the identified candidate CNAs with
the predefined alterations. The performance of the algo-
rithm at different t levels was measured in terms of sen-
sitivity (%; TP/TP + FN) and precision (%; TP/TP + FP)
(Figure 2). We selected these measures to reflect two
critical aspects of the algorithm’s performance: (1) what
percentage of known (simulated) alterations is correctly
identified by the algorithm (sensitivity) and (2) what
percentage of identified alterations by the algorithm are
true positives (precision). Specificity, the percentage of
non-altered regions correctly identified as such, is not as
meaningful in this context because the non-altered
regions comprise a very large fraction of the genome
and specificity becomes less sensitive. Without any
adjustment (t = 0), single copy gains and losses larger
than 20 kb were identified with >90% sensitivity but the
precision level was very low, indicating a high rate of
false positives. With different t levels, a clear trade-off
between sensitivity and precision was observed, as the
increase in threshold improves precision at the expense
of sensitivity. A balanced performance was obtained at t
level around 0.1 (for single copy gains) and 0.16 (losses),
respectively. At these t levels (tgain =0 . 1a n dtloss =
0.16), the algorithm achieved >90% sensitivity and >60%
precision in detecting 100 kb single copy gains and
>80% sensitivity and >80% precision levels for 50-kb sin-
gle copy losses. For single copy gains, the smaller
threshold values (0 <tgain <0 . 1 )a r en o ts u f f i c i e n ti nf i l -
tering out false positives and results in low precision;
higher values (0.1 <tgain < 0.2), on the other hand, are
associated with low sensitivity level. We note that the
optimal threshold values found here are about half of
the threshold values that make the local S of single copy
gains and losses zero (t = 0.2 and t = 0.33, respectively).
For example, consider a single copy gain with nt (tumor
reads) and nn (normal reads) with read ratio (nt/nn)o f
3/2. The t value that makes the sum of weight values to
be zero can be calculated by an equation: WT × nt +
WN × nn -t ×( nt + nn) = 0. If WT = 1 and WN =- 1( NT
= NN), the t is 0.2, the half of which is the empirically
determined optimal tgain. For real data sets, this is a rea-
sonable way to determine the initial value of t.
We further measured the effect of different t levels in
the accuracy of boundary mapping (Figure 3). Both for
the single copy gains and losses, the boundaries of
observed alterations detected at lower t level tend to fall
outside the predefined boundaries, while the opposite is
true for higher t levels. In case of single copy gains, tgain
= 0.1 also showed the highest accuracy in boundary
mapping: 1.3 ± 0.8 kb and 1.5 ± 0.9 kb for start and end
boundaries, respectively, with little dependence on the
alteration size. For single copy losses, the accuracy range
o f0 . 2±0 . 4k ba n d0 . 3±0 . 4k bf o rs t a r ta n de n d
boundaries was observed at tloss of 0.16.
Because this algorithm involves scanning along the
chromosomes, it may not give the same results when
scanned in different directions. To check whether our
method is robust with respect to scanning orientation,
we applied the method in both directions at tgain of 0.1
and tloss of 0.16. Among the observed gains identified by
left-to-right scanning, 88.6% were recovered with the
exactly the same boundaries as by right-to-left scanning.
This coincident rate for boundary mapping was much
higher when considering only true positives (96.7%). In
Kim et al. BMC Bioinformatics 2010, 11:432
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showed matching boundaries in both scanning directions.
The SW-score, which we define to be the local sum of
WT and WN in an identified segment, can be used to
rank identified regions. But this is biased toward a larger
segment, which has a higher probability of generating a
high score. Thus, we also introduce another measure of
significance for each segment as an alternative or addi-
tional filter: the probability of finding the observed or
more extreme distribution of tumor and normal reads
in the identified region given the total number of tumor
and normal reads. This can be done by assuming that
the read density follows the Poisson or normal distribu-
tion. We adapt a statistical method previously described
for differential analysis of sequencing tags based on the
Poisson distribution [19] (see Methods). To see the
effects of the additional screening, the alterations
identified at tgain of 0.1 and tloss of 0.16 were filtered by
their SW-scores (11 scales from 50 to 150) or signifi-
cance levels (11 scales from 10
-5 to 10
-15). The use of
stringent cutoffs in both measures tends to increase pre-
cision when detecting small alterations while maintain-
ing the sensitivity levels of large alterations (see
Additional file 1: Figure S1). In detecting single copy
number gains, for instance, the use of score threshold of
80 or significance of 10
-8 was optimal, showing >90%
sensitivity and >90% precision in detecting 100 kb copy
number gains. The similar performance level was
observed in detecting 100 kb single copy number losses
at the same significance cutoff (see Additional file 1:
Figure S2).
Because the algorithm is dependent on relative tag
density only, we expect that the regions with similar
read numbers can be identified at a similar
Figure 2 The performance of the algorithm in simulation tests. (A) The algorithm was tested for 16 different t values (0 - 0.3; x-axis) in
detecting single copy gains with different sizes (10 kb to 1 Mb). The regions identified by the algorithm were compared with the predefined
alterations. The performance was measured in terms of sensitivity (%; top panel) and precision (%; bottom panel). Each dot in the plot represents
the average of 100 simulation tests. (B) Sensitivity (top) and precision (bottom) levels in detecting single copy losses.
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To test this, we simulated 30 kb and 10 kb single copy
gains with 3 million and 10 million virtual reads in
100 Mb artificial chromosomes (Figure 4). The SW-
score cutoff 80 gave consistent performance level
(>90% sensitivity and >90% precision) for the simulated
alterations that are expected to have approximately 500
reads for the normal sample.
To further investigate dependency on different sequen-
cing depth and to compare the results with SegSeq [15],
we performed simulation tests that accounts for read
mappability. Different sizes (10 kb - 1 Mb; 8 scales) of sin-
gle copy gains and losses were simulated on human chro-
mosome 1 (see Methods), in which random 36 bp reads
were selected with varying sequencing depth (1 - 20 mil-
lion reads) and aligned back to the genome. In this simula-
tion, both algorithms show comparable sensitivity level
with each other in detecting various sized alterations (Fig-
ure 5). The sensitivity level is dependent upon the altera-
tion size and sequencing depth for both algorithms, e.g.,
rSW-seq and SegSeq both showed >90% of sensitivity at
detecting 50 kb alterations with 5 million reads in simu-
lated chromosome (~250 Mb). With low sequencing
depth (<10 million reads in ~250 Mb chromosome), rSW-
seq showed improved precision, indicative of low false
positive rates compared to SegSeq (Figure 5E).
Complex alterations and recursive SW-seq (rSW-seq)
Simulations of a single, isolated alteration in a chromo-
some does not fully represent the complexity of altera-
tions commonly observed in a real cancer genome. For
example, the high amplifications or homozygous dele-
tions of well-known cancer-related genes such as EGFR
and CDKN2A frequently occur within low-level
Figure 3 Accuracy in mapping boundaries. (A) The differences between observed and known boundaries of alterations are measured for
different values of the threshold t. The distance (kb) was measured separately for the start (grey, closed) and end points (open) between the
observed and predefined alterations. The relative location of mapped boundaries are divided into those located inside and outside of the
predefined alterations. The inset magnifies the section for tgain of 0.08 to 0.14. The error bar shows the 95% confidence interval. (B) The
measurement is repeated for single copy loss.
Figure 4 Performance of the algorithm at different genome
coverage. Performance in identification of different size alterations
was measured at different coverage levels. Besides the 100 kb
alterations simulated at 0.36× coverage, the 1× and 3× coverage
levels were simulated by putting 3 million and 10 million reads on
100 Mb, respectively. Sensitivity (S) and precision (P) were measured
at different SW-score cutoffs.
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Page 6 of 13Figure 5 Simulation tests on rSW-seq and SegSeq. Different sizes (10 kb to 1 Mb) of single copy gains and losses were simulated on human
chromosome 1. A hundred test chromosomes were simulated at varying sequencing depths (1 to 20 million reads). The sensitivity in detecting
simulated alterations by rSW-seq is shown for single copy gain (A) and loss (B). The same simulation sequencing data was also analyzed
by SegSeq, which show similar sensitivity in detecting copy number gain (C) and loss (D). The precision levels are shown for rSW-seq and
SegSeq in (E).
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simple chromosomal scan might miss such embedded
high copy number changes, which frequently harbor
important cancer-related genes. To distinguish these
focal amplifications, the algorithm described above can
be applied in a recursive manner by exploiting the fact
that focal amplification is a relative copy number gain
with respect to the single copy gain background.
T h u s ,u s i n gt h es i n g l ec o p yg a i na sat e m p l a t e ,t h e
recursive SW-seq (rSW-seq) can identify a focal, high-
level amplification.
To test this, we simulated 1 Mb single copy gains (3
copies) containing a smaller (50 kb, 100 kb, 200 kb, and
300 kb) two copy gain (4 copies) in 100 Mb artificial
chromosomes. The alteration found in the first scan was
used as template for the second scan of the algorithm.
The performance of the second scan in identifying the
implanted two copy gains was measured with different
tgain levels (Figure 6A). The 100 kb two copy gains were
identified at >80% sensitivity and >80% precision at tgain
0.06. The smaller copy number ratio (4 vs 3 copies) is
responsible for the smaller tgain compared to the
Figure 6 Simulation tests for complex alterations and performance of rSW-seq. (A) The performance in identification of focal, two copy
number changes (4 copies) of various sizes (50 kb–300 kb) from 1 Mb single copy gains. The sensitivity (S) and precision (P) are shown for four
size categories at different t levels. (B) The homozygous deletions (zero copy) nested in single copy losses were similarly tested. (C) Five
alterations with different copy numbers (0 ~ 4 copies) are positioned in a complex configuration. The alterations are indexed (#1 - #5) in
chromosomal order. The focal high-level amplification (#2) and homozygous deletion (#5) are nested within the larger single copy gain (#1) and
loss (#4) (D) The observed alterations identified by rSW-seq were classified according to their expected copy numbers and compared with the 5
predefined alterations.
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copies vs 2). Focal homozygous deletions (zero copy)
nested in single copy number losses (1 copy) were also
simulated and tested for the performance (Figure 6B). In
this case, the decrease in sensitivity level was not
observed with higher tloss level, possibly due to the
absence of tumor reads in the homozygous deletion.
The use of tloss 0.16 was able to detect all tested sizes of
homozygous deletions with >90% sensitivity and >90%
precision.
We also simulated a set of complex alterations that
contain 2 single copy gains (3 copies; 1 Mb) and a single
copy loss (1 copy; 500 kb) as well as 1 high-level ampli-
fication (4 copies; 100 kb) and homozygous deletion
(zero copy; 100 kb) in a single profile (Figure 6C). rSW-
seq was able to identify focal high-level amplification
and homozygous deletion separately from their nested
larger single copy gain and loss. We also note that a
small region with no copy number change that separates
large single copy gain can be identified as an isolated
alteration, e.g., single copy loss with respect to single
copy gain. The observed alterations found in 100 recur-
sive tests were compared with the simulated alterations
with the matched copy numbers to measure the perfor-
mance of rSW-seq (Figure 6D). Not surprisingly, it
shows that the performance of rSW-seq at identifying
multilayered alterations is highly influenced by the copy
number differences in the nested alterations, e.g., rela-
tively poor performance for high-level amplification
(4 copies) nested in single copy gain (3 copies).
The performance of rSW-seq in real sequencing data
To test the performance of the algorithm in real sequen-
cing data, we applied rSW-seq to the sequencing data
initially analyzed by SegSeq [15]. This dataset contained
three pairs of cancer- derived cell lines (tumor and
matched normal), each of which was comprised of 25 -
35 million reads. The dataset also includes genomic
profiles generated on the same samples using high-reso-
lution array-CGH platform (Affymetrix genomewide
SNP 6.0) that can be used for comparison. rSW-seq was
applied using the t levels determined in simulation tests
and a score cutoff of 100. Then we compared the results
of rSW-seq with those of SegSeq for segments corre-
sponding to copy number gains (read ratio >1.5) and
losses (read ratio <0.5) in each of the three cell lines for
the total of six comparisons (Table 1). We found a high
level of concordance (79.7% - 98.6%) between the seg-
mentation results of rSW-seq and SegSeq, where the
concordance was defined as the fraction of overlapping
region identified by the two methods over the total seg-
ments size found in either method. When the results
are compared with independent segmentation results
obtained from Affymetrix array-CGH, rSW-seq showed
higher concordance rates as compared with SegSeq in 5
out of 6 comparisons.
The individual chromosomal profiles obtained by
rSW-seq and SegSeq are notably similar (see Additional
file 1: Figure S3). For example, in chromosome 11 in the
tumor cell line HCC1954, two methods show similar
profiles overall, which is also consistent with array-CGH
results (Figure 7A). A focal amplification residing at ~70
Mb of chromosome 11 (11q13) contains well-known
cancer genes FGF3, FGF4 and CCND1 and appears as a
dominant peak in read ratios both for rSW-seq and Seg-
S e qa sc o m p a r e dt ot h eh y b r i d ization-based intensity
ratio. Such is indicative of the higher dynamic range of
the sequencing-based measures, as previously shown for
ERBB2 amplification in the same dataset HCC1954 [15].
For the 4 high-level amplifications by SegSeq showing
read ratio >8 (5p15, 8q23 and 17q12 on HCC1954 and
19p13 on HCC1143), all were recovered by rSW-seq.
There are some differences in the two profiles as well.
One is a high-level amplification identified by rSW-seq
on 14q32 in HCC1954 (Figure 7B). This amplification is
supported by the array-CGH profile and it contains loci
for breast cancer-related signaling molecule AKT1 [20]
in this breast cancer cell line. With respect to candidates
for homozygous deletions, three loci in H2347 were
coincident between rSW-seq and SegSeq (6q24, 9p23
and 17p12). But rSW-seq also identified 5 additional
candidates for homozygous deletions in HCC-1143,
which include cancer-related genes such as TRAPPC6B
(14q21), AML1 and RUNX1 (both on 21q22), worthy of
further investigation.
It should be noted that our simulation tests above are
based on idealized copy number ratios for CNAs, e.g., 3/
2 of tumor and normal read ratio for single copy gain.
Considering the tissue heterogeneity in tumors, this is
unlikely to be true in actual data. It is possible that the
methods used here for cell line-derived data may require
additional optimization for analysis of sequencing data
from primary cancer cells.
Conclusions
We have proposed rSW-seq as an iterative method that
can be used to discover CNAs efficiently, including
those in a complex configuration. Among the methods
for single-end read-based copy number analysis
[11,12,18], SegSeq and rSW-seq are similar in that they
are designed to make CNA calls by direct comparison
of tumor and paired normal genomes [15]. One key dif-
ference, however, is that SegSeq first identifies the
potential breakpoints (point-centric) and merges neigh-
boring windows to obtain candidate segments, while
rSW-seq directly captures potential CNAs as regions
with substantial bias in tumor vs normal reads counts
(region-centric). Global algorithms such as rSW-seq are
Kim et al. BMC Bioinformatics 2010, 11:432
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more subtle CNAs, for which point-centric algorithms
might miss boundaries that do not show clear differ-
ences in read density. In our simulation, rSW-seq
showed improved performance compared to SegSeq
(e.g., better precision at comparable sensitivity level,
Figure 5). An important advantage of rSW-seq also is
that a window size, which can change the results sub-
stantially for SegSeq, does not need to be specified.
However, the performance of the algorithms in real
Table 1 Comparison of overlap between alterations
Ratio Method HCC1143 HCC1954 H2347
Concordance rate (%)
a >1.5 rSW-seq 94.2 90.9 97.4
SegSeq 83.6 79.7 99.5
<0.5 rSW-seq 93.0 97.1 98.6
SegSeq 91.0 93.2 93.8
Concordance rate vs array-based profile (%)
b >1.5 rSW-seq 96.8 96.4 70.0
SegSeq 95.4 94.6 26.3
<0.5 rSW-seq 83.9 57.2 42.4
SegSeq 76.9 57.8 33.5
aConcordance rate was measured between the results of rSW-seq and SegSeq, and is defined as (overlapping region between two methods in bp)/(total regions
identified by either rSW-seq or Segseq in bp).
bConcordance rate is (overlapping region between array-based and sequencing based in bp)/(regions identified by
array-based or sequencing-based in bp).
Figure 7 The comparison of three segmentation profiles. (A) The segmentation results for chromosome 11 in HCC1954 are shown for the
two sequencing-based methods, rSW-seq (top) and SegSeq (middle), and for an array-based method (bottom). The profiles are very similar in
this case. The arrow indicates a high-level amplification peak located at 11q13, where the array-based profile gives a reduced signal. (B) Three
plots of chromosome 14 are also shown for the same cell line. The arrow indicates the high-level amplification at 14q32, which is observed in
the rSW-seq and array-based profiles.
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likely, these methods should complement each other in
making reliable calls for candidate CNAs. When the
data consists of paired-end reads (PEM), the algorithms
[21,22] designed for such data should also provide com-
plementary information.
As next-generation sequencing becomes more widely
available, more whole-genome sequencing data will be
generated for cancer studies. rSW-seq provides a solu-
tion for effective screening of cancer-specific CNAs for
better understanding of the tumor biology and discovery
of biomarkers.
Methods
Details of the algorithm
Given NT and NN as the total number of tumor and
normal reads in the dataset, respectively, the copy num-
ber gain-detection algorithm is presented in the follow-
ing pseudocode.
1 WT =2×NN/(NT + NN), WN =- 2×NT/(NT + NN)
2 k =1
3 Repeat
4 S =0 ,l =1 ,Smax =0
5 For i in 1 to NT + NN
6i f ri is tumor and unmasked then S = S + WT
7i f ri is normal and unmasked then S = S + WN
8i f S >Smax then Smax = S, lmax = l, mmax = i
9i f S < 0 then S =0 ,l = i +1
10 End For
11 Report Smax,l max,m max
12 Mask ri from lmax to mmax
13 k = k +1
14 Until Smax =0
Each chromosome scan produces a single CNA candi-
date, and the scanning iterates until no more positive-
scoring segments can be found. The reads correspond-
ing to the identified CNAs are masked before the itera-
tion continues. The computational complexity is 0(k ×
(NT + NN)) When k represents the number of CNAs
detected. It is of note that the NT and NN are the read
number of entire dataset each from tumor and matched
normal sequencing dataset.
In the following we show that the segment
[, ] ss lm max max identified in the above pseudocode is the
maximum segment. Note that the segment [, ] ss lm max max
i st h es a m ea s SS lm kk 00 , ⎡
⎣
⎤
⎦ in the main text. We will
use SS lm kk 00 , ⎡
⎣
⎤
⎦ to refer to the segment identified in
the above pseudocode.
Proposition
The segment SS lm kk 00 , ⎡
⎣
⎤
⎦ is the maximum segment.
Proof. Assume that [sl,s m]i st h es e g m e n tt h a tm a x i -
mizes the partial cumulative sum Slm W j jl
m
(, )=
= ∑
Without loss of generality, we assume S(l, m) > 0 (other-
wise, there will be no tumor read and no copy gain
region will be identified).
Remember that K is the integer such that S(lk,i )>0
for all i ≥ lk. We first prove the following remark.
Remark
For each k = 1,...,K, S(lk,m k) = max{S(i, j),lk ≤ i ≤ j <lk+1}.
Case1: k = K. For any lk ≤ i ≤ j <lk + 1 We have S(lk,j )
= S(lk,i-1 )+S(i, j) (define S(lk,l k-1) as 0). By the defi-
nition of k we have S(lk,l k-1) ≥ 0 Thus, S(lk,m k) ≥ S(lk,
j) ≥ S(i, j) and henc S(lk,m k) = max{S(i, j),lk ≤ i ≤ j <lk+1}
Case 2: k <K.I flk = lk+1 -1, the remark holds immedi-
ately. Assume lk <lk+1 -1w et h e nh a v eS(lk,i )>0f o ra l l
lk ≤ i ≤ lk+1 -2, since lk+1 -1 is the first index after lk such
that S(lk,i )<0( i ≥ lk). Suppose that S(i0,j0)=m a x { S(i, j),
lk ≤ i ≤ j <lk+1}W eh a v e ,S(lk,i 0)=S(lk,i 0 -1 )+S(i0,j0)
≥ S(i0,j0), where the equality holds if and only if lk = i0.
Thus, we get lk = i0.O nt h eo t h e rh a n d ,s i n c eS(lk,m k)
≥ S(lk,i ) for all lk ≤ i <lk+1, we have S(lk,m k) ≥ S(lk,j 0)=S
(i0,j0) and S(lk,m k) = max{S(i, j), lk ≤ i ≤ j <lk+1}.
Now we prove SS lm kk 00 , ⎡
⎣
⎤
⎦ is the maximum segment
[sl,s m]. Let 1 ≤ k1 ≤ k2 ≤ K be the integer such that
ll l kk 11 1 ≤< + and lm l kk 22 1 ≤<+ .
If k1 = k2,w eh a v ell m l kk 11 1 ≤≤ < + .A c c o r d i n gt ot h e
above remork, we haveSl m Slm Sl m Sl m kk kk kk ( ,)( , )( , )( ,)
11 00 11 ≥≥ ≥
and hence SS lm kk 00 , ⎡
⎣
⎤
⎦ is the maximum segment.
If k1 <k2,w eh a v ell l m l kk k 11 2 11 ≤< ≤ < ++ .I f
ll k =− + 1 1 1, we have S(l, l)<0 .
However, S(l, m)=S(l, l)+S(l +1 ,m)< S(l +1 ,m),
which contradicts the fact that [sl,s m] is the maximum
segments. Hence, we have ll l kk ≤< − + 1 1 1. Thus,
Sl l k (, )
1 10 −≥ .S i n c eSl l Sl l Sll kk k k () ( , ) ( , )
11 1 1 11 11 1 0 ++ −= −+ −<   ,
we have Sll k (, )
1 1 10 + −<. Thus, Slm Sll Sl m Sl m kk k (, ) (, ) ( , ) ( , ) =− + < ++ + 11 1 11 1 1 ,
which again contradict the fact that [sl,s m]i st h em a x i -
mum segments. Hence the proposition was proved.
Simulation tests
We simulated 100 Mb artificial chromosomes that con-
tain a million virtual tags split equally between tumor (T)
and normal (N) reads. To simulate normal reads, we ran-
domly placed a half million tags across the chromosome.
Tumor reads were positioned to simulate tumor-specific
single copy gain (3 copies) and loss (1 copy) with respect
to the normal genome (2 copies). To simulate a 1 Mb
single copy gain, for example, we randomly assigned the
positions of a half million tags across 100.5 Mb chromo-
some. Then, the tags corresponding to the additional 0.5
Mb segment were moved to a predefined 1 Mb segment
Kim et al. BMC Bioinformatics 2010, 11:432
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single copy loss, one half of tumor reads were randomly
positioned but excluded in a predefined segment corre-
sponding to single copy loss, while the other half of
tumor reads were positioned across the chromosome.
Alterations identified by the algorithm were compared
with the predefined alterations by the extent of overlap
(true positive, TP). The means of false negative (FN) and
positive (FP) rates were also calculated for 100 artificial
chromosomes to measure sensitivity (%; TP/TP + FN)
and precision (%; TP/TP + FP).
To measure the accuracy of boundary mapping, the
separating distance (bp) between the boundaries of esti-
mated and predefined alterations were measured. In case
of multiple alterations in a single chromosome, the most
left- and right-ward boundaries were selected as start and
end points of observed alterations. The differences in the
boundary mappings were measured separately for the
observed boundaries that reside in- or outside the prede-
fined alterations. We also tested the robustness of algo-
rithm in scanning orientation using the same set of
artificial chromosomes. For each of observed alteration
found in the left-to-right orientation, we checked
whether the same alteration was identified by the reverse
(right-to-left) scanning. The effect of subsequent score
and significance-based threshold was assessed by filtering
out the observed alterations using 11 scales of SW scores
(50 to 150) or significance-cutoffs (10
-5 to 10
-15). The
performance testing at different coverage level was per-
formed by placing 3 million and 10 million virtual tags
on 100 Mb artificial chromosomes.
To measure the significance level of observed altera-
tions, we counted the number of tumor and normal
reads within the alteration and used a statistical method
previously described for differential analysis of sequen-
cing tags [19]. According to this model, the probability
of observing t tumor reads in a defined segment con-
taining n normal reads can be calculated assuming ran-
dom distribution of sequencing reads and given NT and
NN. For copy number losses (t/n <NT/NN), the probabil-
ity of observing less than or equal to t number of tumor
reads with n normal reads is the following [19]:
Pt nN N
NT
NN
in
in
NT
NN
in TN
i
t
i
(|, )
() !
!!
() , =
⎛
⎝
⎜
⎞
⎠
⎟
+
+
⎛
⎝
⎜
⎞
⎠
⎟
++
= ∑
0 1
1
For copy number gain (t/n >NT/NN), the probability of
observing equal to or more than t tumor reads is 1 - P(t -1 | n).
For the second set of simulations based on a test
chromosome from a real genome, we used the human
chromosome 1 (~250 Mb) as a template. To simulate
copy number changes, we used a strategy described pre-
viously [18]. First, we randomly selected two chromoso-
mal positions (’source’ and ‘target’) and the sequence of
defined size (10 kb - 1 Mb; 8 scales) at the source posi-
tion was copied into the target position. This results in
copy number gain and loss at the source and target
positions, respectively. For an individual test chromo-
some, 16 alterations (8 copy gains and 8 copy losses in
different sizes) were simulated at random positions. The
test chromosome was further concatenated to an unmo-
dified template sequence, making the simulated altera-
tions correspond to single copy gains and losses. To
account for mappability, 36 bp reads were randomly
selected from simulated chromosomal sequence and
mapped using Bowtie [23], keeping only uniquely
mapped reads. Sequencing depths of 1 million to 20
million reads were tested. In case of rSW-seq, we used
the optimized setting (SW-score of 80 and threshold
level of tgain=0 . 1a n dtloss =0 . 1 6 ) .F o rS e g S e q ,w eu s e d
default parameter setting except for the window size w
(w = 400 for 1 - 5 million reads and w = 1000 for 10 -
20 million reads) since the use of default parameter
(w = 400) at higher coverage showed poor performance
(<80% of sensitivity for single copy gains <500 kb).
Datasets
Sequencing data for the three cell line pairs of tumor and
matched normal genomes (HCC1954, HCC1143 and
H2347) were downloaded from accompanying website for
SeqSeq [15]. For the comparison of the results obtained by
rSW-seq, we used the segmentation results of the same
datasets analyzed with SegSeq at its default setting. The
profiles of the same cell line pairs obtained from the Affy-
metrix SNP 6.0 platforms were also downloaded from the
same website. We calculated the log2 ratios of the signal
intensities form tumor and paired normal lines and per-
formed the segmentation using CBS algorithm [17].
Code availability
Available upon request.
Additional material
Additional file 1: Supplementary Figures. Figure S1: Effect of filtering
by score and significance thresholds for gains. Figure S2: Effect of
filtering by score and significance thresholds for losses. Figure S3:
Comparison of chromosomal profiles.
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